LINC01089 Blocks the Proliferation and Metastasis of Colorectal Cancer Cells via Regulating miR-27b-3p/HOXA10 Axis

References

• Moreno EC, Pascual A, Prieto-Cuadra D, et al. Novel molecular characterization of colorectal primary T umors based on miRNAs. Cancers. 2019;11:3. doi:10.3390/cancers11030346
   Web of Science ®Google Scholar
• Cantero-Cid R, Casas-Martin J, Hernández-Jiménez E, et al. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells? BMC Cancer. 2018;18(1):945. doi:10.1186/s12885-018-4853-030285662
   PubMedGoogle Scholar
• Yuan Y, Sun S, Jiao N, Shu Y, Zhang Y. Upregulation of HOXA10 protein expression predicts poor prognosis for colorectal cancer. Genet Test Mol Biomarkers. 2018;22(6):390–397. doi:10.1089/gtmb.2017.024029870276
   PubMed Web of Science ®Google Scholar
• Yang L, Xie N, Huang J, et al. SIK1-LNC represses the proliferative, migrative, and invasive abilities of lung cancer cells. Onco Targets Ther. 2018;11:4197–4206. doi:10.2147/OTT.S16527830050311
   PubMed Web of Science ®Google Scholar
• Wang YL, Liu JY, Yang JE, et al. Lnc-UCID promotes G1/S transition and hepatoma growth by preventing DHX9-mediated CDK6 down-regulation. Hepatology. 2019;70(1):259–275. doi:10.1002/hep.3061330865310
   PubMed Web of Science ®Google Scholar
• Yoshimura H, Matsuda Y, Yamamoto M, Kamiya S, Ishiwata T. Expression and role of long non-coding RNA H19 in carcinogenesis. Front Biosci. 2018;23:614–625. doi:10.2741/4608
   PubMed Web of Science ®Google Scholar
• Cho SW, Xu J, Sun R, et al. Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element. Cell. 2018;173(6):1398–1412. doi:10.1016/j.cell.2018.03.06829731168
   PubMed Web of Science ®Google Scholar
• Ji D, Zhong X, Jiang X, et al. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathol Res Pract. 2018;214(10):1524–1531. doi:10.1016/j.prp.2018.08.01430173945
   PubMed Web of Science ®Google Scholar
• Gu LQ, Xing XL, Cai H, et al. Long non-coding RNA DILC suppresses cell proliferation and metastasis in colorectal cancer. Gene. 2018;666:18–26. doi:10.1016/j.gene.2018.03.10029621586
   PubMed Web of Science ®Google Scholar
• Li QG, Xu XQ, Zhou DY, et al. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer. Eur Rev Med Pharmacol Sci. 2019;23(8):3320–3325. doi:10.26355/eurrev_201904_1769431081085
   PubMed Web of Science ®Google Scholar
• Cui ZH, Han BB, Wang XR, Li ZW, Wang JX, Lv YF. Long non-coding RNA TTN-AS1 promotes the proliferation and invasion of colorectal cancer cells by activating miR-497-mediated PI3K/Akt/mTOR signaling. Onco Targets Ther. 2019;12:11531–11539. doi:10.2147/OTT.S22910431920341
   PubMed Web of Science ®Google Scholar
• Jin FS, Wang HM, Song XY. Long non-coding RNA TCF7 predicts the progression and facilitates the growth and metastasis of colorectal cancer. Mol Med Rep. 2018;17(5):6902–6908. doi:10.3892/mmr.2018.870829532890
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang G, Zheng W, et al. MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2. Biosci Rep. 2018;38(6). doi:10.1042/BSR20181436
   Google Scholar
• Li T, Pan H, Li R. The dual regulatory role of miR-204 in cancer. Tumour Biol. 2016;37(9):11667–11677. doi:10.1007/s13277-016-5144-527438705
   PubMedGoogle Scholar
• Mohammadi Torbati P, Asadi F, Fard-Esfahani P. Circulating miR-20a and miR-26a as biomarkers in prostate cancer. Asian Pac J Cancer Prev. 2019;20(5):1453–1456. doi:10.31557/APJCP.2019.20.5.145331127907
   PubMedGoogle Scholar
• Chen E, Li Q, Wang H, et al. MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5. Biomed Pharmacother. 2018;106:1046–1051. doi:10.1016/j.biopha.2018.07.05030119170
   PubMed Web of Science ®Google Scholar
• Chen E, Li Q, Wang H, Yang F, Min L, Yang J. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study. Biomed Pharmacother. 2018;106:1370–1377. doi:10.1016/j.biopha.2018.07.09830119209
   PubMed Web of Science ®Google Scholar
• Li Y, Duo Y, Bi J, et al. Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy. Int J Nanomedicine. 2018;13:1241–1256. doi:10.2147/IJN.S15829029535520
   PubMed Web of Science ®Google Scholar
• O’Brien SJ, Carter JV, Burton JF, et al. The role of the miR-200 family in epithelial-mesenchymal transition in colorectal cancer: a systematic review. Int J Cancer. 2018;142(12):2501–2511. doi:10.1002/ijc.3128229388209
   PubMed Web of Science ®Google Scholar
• Yang X, Chen J, Liao Y, et al. MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10. Biosci Rep. 2019;39(12). doi:10.1042/BSR20191087
   Google Scholar
• Li B, Shi C, Zhao J, Li B. Long noncoding RNA CCAT1 functions as a ceRNA to antagonize the effect of miR-410 on the down-regulation of ITPKB in human HCT-116 and HCT-8 cells. Oncotarget. 2017;8(54):92855–92863. doi:10.18632/oncotarget.2161229190961
   PubMedGoogle Scholar
• Ruiz-López L, Blancas I, Garrido JM, et al. The role of exosomes on colorectal cancer: a review. J Gastroenterol Hepatol. 2018;33(4):792–799. doi:10.1111/jgh.1404929156509
   PubMed Web of Science ®Google Scholar
• Sas-Chen A, Aure MR, Leibovich L, et al. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Mol Med. 2016;8(9):1052–1064. doi:10.15252/emmm.20160619827485121
   PubMed Web of Science ®Google Scholar
• Yuan H, Qin Y, Zeng B, et al. Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer. Onco Targets Ther. 2019;12:4883–4895. doi:10.2147/OTT.S20883031417284
   PubMed Web of Science ®Google Scholar
• Gu J, Xu F, Dang Y, Bu X. Long non-coding RNA 001089 is a prognostic marker and inhibits glioma cells proliferation and invasion. Clin Lab. 2019;65(3). doi:10.7754/Clin.Lab.2018.180817
   Web of Science ®Google Scholar
• Shuwen H, Qing Z, Yan Z, Xi Y. Competitive endogenous RNA in colorectal cancer: a systematic review. Gene. 2018;645:157–162. doi:10.1016/j.gene.2017.12.03629273554
   PubMed Web of Science ®Google Scholar
• Wang H, Wang G, Gao Y, et al. Lnc-SNHG1 activates the TGFBR2/SMAD3 and RAB11A/Wnt/β-catenin pathway by sponging MiR-302/372/373/520 in invasive pituitary tumors. Cell Physiol Biochem. 2018;48(3):1291–1303. doi:10.1159/00049208930048990
   PubMedGoogle Scholar
• Chen D, Si W, Shen J, et al. miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells. Cell Death Dis. 2018;9(2):188. doi:10.1038/s41419-017-0211-429416005
   PubMedGoogle Scholar
• Sun W, Zhang LW, Yan RR, Yang Y, Meng XL. LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis. Onco Targets Ther. 2019;12:3945–3954. doi:10.2147/OTT.S19686531190891
   PubMedGoogle Scholar
• Tao J, Zhi X, Zhang X, et al. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. J Exp Clin Cancer Res. 2015;34(1):139. doi:10.1186/s13046-015-0253-326576539
   PubMedGoogle Scholar
• Liu L, Hu J, Yu T, et al. miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through snail-mediated pathway. Acta Biochim Biophys Sin (Shanghai). 2019;51(5):492–500. doi:10.1093/abbs/gmz03031006800
   PubMed Web of Science ®Google Scholar
• Xu Y, Han YF, Ye B, et al. miR-27b-3p is involved in doxorubicin resistance of human anaplastic thyroid cancer cells via targeting peroxisome proliferator-activated receptor gamma. Basic Clin Pharmacol Toxicol. 2018;123(6):670–677. doi:10.1111/bcpt.1307629924913
   PubMed Web of Science ®Google Scholar
• Zanatta A, Rocha AM, Carvalho FM, et al. The role of the Hoxa10/HOXA10 gene in the etiology of endometriosis and its related infertility: a review. J Assist Reprod Genet. 2010;27(12):701–710. doi:10.1007/s10815-010-9471-y20821045
   PubMed Web of Science ®Google Scholar
• Oakley K, Han Y, Vishwakarma BA, et al. Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10. Blood. 2012;119(25):6099–6108.33. doi:10.1182/blood-2011-10-38871022566606
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang Y, Wan Y, Zhou S, Thapa S, Cheng W. MicroRNA665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10. Mol Med Rep. 2018;18(3):2661–2668. doi:10.3892/mmr.2018.925230015865
   PubMed Web of Science ®Google Scholar
• Zhang HY, Li JH, Li G, Wang SR. Activation of ARK5/miR-1181/HOXA10 axis promotes epithelial-mesenchymal transition in ovarian cancer. Oncol Rep. 2015;34(3):1193–1202. doi:10.3892/or.2015.411326151663
   PubMed Web of Science ®Google Scholar
• Chen W, Wu G, Zhu Y, et al. HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway. Cancer Manag Res. 2019;11:6625–6635. doi:10.2147/CMAR.S20134231406476
   PubMed Web of Science ®Google Scholar
• Chen R, Li H, Li Y, et al. Loss of nuclear functions of HOXA10 is associated with testicular cancer proliferation. Front Oncol. 2018;8:594. doi:10.3389/fonc.2018.0059430581773
   PubMed Web of Science ®Google Scholar
• Chu MC, Selam FB, Taylor HS. HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells. Cancer Biol Ther. 2004;3(6):568–572. doi:10.4161/cbt.3.6.84815044858
   PubMed Web of Science ®Google Scholar
• Sun S, Su C, Zhu Y, et al. MicroRNA-544a regulates migration and invasion in colorectal cancer cells via regulation of homeobox A10. Dig Dis Sci. 2016;61(9):2535–2544. doi:10.1007/s10620-016-4186-227165435
   PubMed Web of Science ®Google Scholar